A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by NCIC Clinical Trials Group
Sponsor:
Information provided by (Responsible Party):
NCIC Clinical Trials Group
ClinicalTrials.gov Identifier:
NCT01396408
First received: July 14, 2011
Last updated: September 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)